Aemetis, Inc. (NASDAQ:AMTX) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Aemetis, Inc. (NASDAQ:AMTX) have earned an average rating of “Moderate Buy” from the five analysts that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $12.95.

A number of research firms have recently issued reports on AMTX. HC Wainwright reissued a “buy” rating and issued a $28.00 price target on shares of Aemetis in a research note on Monday, December 23rd. StockNews.com raised shares of Aemetis to a “sell” rating in a research note on Friday, January 3rd.

Institutional Investors Weigh In On Aemetis

Several large investors have recently added to or reduced their stakes in the business. State Street Corp grew its holdings in Aemetis by 36.1% during the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after acquiring an additional 185,304 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in Aemetis during the 2nd quarter worth approximately $306,000. Susquehanna Fundamental Investments LLC grew its holdings in Aemetis by 287.4% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after acquiring an additional 93,536 shares in the last quarter. Wellington Management Group LLP acquired a new position in Aemetis during the 3rd quarter worth approximately $177,000. Finally, Geode Capital Management LLC grew its holdings in Aemetis by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock worth $2,126,000 after acquiring an additional 66,031 shares in the last quarter. 27.02% of the stock is owned by hedge funds and other institutional investors.

Aemetis Price Performance

Shares of AMTX stock opened at $2.87 on Monday. The firm’s 50-day moving average is $3.28 and its two-hundred day moving average is $2.97. Aemetis has a 12 month low of $2.10 and a 12 month high of $7.03. The company has a market capitalization of $142.74 million, a PE ratio of -1.27 and a beta of 1.47.

Aemetis (NASDAQ:AMTX) last issued its earnings results on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The firm had revenue of $81.44 million for the quarter, compared to analysts’ expectations of $77.79 million. During the same period last year, the firm earned ($0.59) earnings per share. Sell-side analysts forecast that Aemetis will post -2.02 EPS for the current year.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.